Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis
about
Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: A systematic review and meta-analysisAdvances in the prevention, management, and treatment of community-acquired pneumoniaImpact of the Tohoku earthquake and tsunami on pneumonia hospitalisations and mortality among adults in northern Miyagi, Japan: a multicentre observational studySurveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficileComparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective dataHealthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-AnalysisSepsis and Other Infectious Disease Emergencies in the Elderly.Modified IDSA/ATS Minor Criteria for Severe Community-Acquired Pneumonia Best Predicted MortalityPhenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis.Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohortSerum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort studyImprovement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia.Persistent recurring wheezing in the fifth year of life after laboratory-confirmed, medically attended respiratory syncytial virus infection in infancy.Development of a risk-adjusted in-hospital mortality prediction model for community-acquired pneumonia: a retrospective analysis using a Japanese administrative databasePneumonia severity, comorbidity and 1-year mortality in predominantly older adults with community-acquired pneumonia: a cohort study.Characteristics associated with clinician diagnosis of aspiration pneumonia: a descriptive study of afflicted patients and their outcomes.Severity assessment of lower respiratory tract infection in Malawi: derivation of a novel index (SWAT-Bp) which outperforms CRB-65.Defining severe pneumonia.Prognostic utility of serum CRP levels in combination with CURB-65 in patients with clinically suspected sepsis: a decision curve analysis.Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.Effectiveness of Proadrenomedullin Enhanced CURB65 Score Algorithm in Patients with Community-Acquired Pneumonia in "Real Life", an Observational Quality Control Survey.The Pneumonia Severity Index as a Predictor of In-Hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseA mortality prediction rule for non-elderly patients with community-acquired pneumoniaThe International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: rationale, design and description of study cohorts and patients.A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.Predicting the Risk of Readmission in Pneumonia. A Systematic Review of Model PerformanceAn Elevated Glycemic Gap is Associated With Adverse Outcomes in Diabetic Patients With Community-Acquired PneumoniaDiagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scanGuidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio.Healthcare-associated Pneumonia: Clinical Features and Retrospective Analysis Over 10 Years.Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial.The bronchiectasis severity index. An international derivation and validation study.Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis.Elderly patients with community-acquired pneumonia: optimal treatment strategies.Predicting mortality with severity assessment tools in out-patients with community-acquired pneumonia.Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis.Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease.Prediction of prognosis by markers in community-acquired pneumonia.Defining severity in non-cystic fibrosis bronchiectasis.
P2860
Q26747529-AF9793E9-512D-4364-8C10-5BA3AD143EAFQ26753138-2A26CBBE-0D60-423E-B1FF-D088A1A7C6FBQ28383466-C529EE59-7A46-49EE-9FCC-630C4DC0CBEAQ28728656-684D52DC-564C-4EF1-92F1-7559F92BAC88Q28730789-30A31D29-6123-429F-8036-B5769535572FQ29543747-BBEE3B87-7C47-47D8-8A80-A23B33304056Q30248705-57C0148B-F81D-4C2D-BA3F-6A73910E61E7Q33425748-3D497D43-2917-49F2-BD83-D280F5B8CA06Q33586621-7CF2CEA4-6151-4F2F-8EFF-6A47F8077A5DQ33630499-A9F6315A-2F14-4D4A-AC2A-65FF8AD4AC81Q34231948-A6F3B53E-8F3E-4A48-8A6A-3A9510409ED7Q34419979-C2145F4C-E9C3-4627-ADD3-E6FC7CA60E8FQ34778067-AE4651AC-75DF-4C16-B812-18933BE62990Q34788533-A43E63F1-3C48-4866-B1FD-49268B768424Q35007069-3719ECF2-BDE2-4AC3-8754-70239BE01C03Q35027982-A6315C2E-1F4D-4A48-8E43-AAFA605CDD9AQ35064123-F4908450-8AA3-43EA-A679-762CA62E384EQ35184605-41DD51E6-A58D-4105-8A0C-B6094207A693Q35573052-33E82BED-9739-443F-935B-A76FFB64891CQ35648136-BCD493F0-18E8-408B-8896-B767686EE931Q35667182-8C7389ED-F025-4E69-8165-88259092B0BDQ35695038-4A972EA3-5AEB-43EA-BDB0-413D09927F00Q35949943-CB83DEFE-E038-444F-A193-90F9A6E70DFFQ35981786-55EC460E-6767-4E27-B98D-6EA9CDA31BF5Q36015061-9D4EA4A2-C918-4CB8-8367-AC97B411BED7Q36051646-7107B3D9-E91D-4CC5-BA54-B8800A4A5733Q36153054-F39D34B7-C364-4C88-A756-74A1F41807CCQ36169564-AA8AC7BA-4E30-48E7-BBD6-51BC7C109C32Q36281234-692029F3-50AC-4026-832D-CBE4350C5DFAQ36310667-914EDC26-E312-447B-8EAA-D0DCFE58F2B9Q36531884-E5A3EC44-3E89-468F-BFD1-282E02E77E20Q37209299-595D5E75-334A-48F5-8CB5-4F69BC6546B4Q37688482-F91A6669-57AA-40CC-8277-C7E8E5BE6180Q37887560-4E901975-658A-4E32-A900-856FCBA47BB3Q37896600-9880121B-A7D1-492D-A8CD-7A3A7BCA4AB1Q37902371-62495B5E-B745-4320-B3CA-99303F5E212DQ38030062-611B722C-2B19-43FD-BAFA-DF78FAF0B419Q38100840-53EE76FB-B363-4BA7-8384-046AE5C51E60Q38140013-56929E86-4582-464D-A92E-6BC65DBD9D5FQ38193861-D13679D8-7D83-4A98-BD97-072A0D589DB8
P2860
Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Severity assessment tools for ...... matic review and meta-analysis
@ast
Severity assessment tools for ...... matic review and meta-analysis
@en
Severity assessment tools for ...... matic review and meta-analysis
@nl
type
label
Severity assessment tools for ...... matic review and meta-analysis
@ast
Severity assessment tools for ...... matic review and meta-analysis
@en
Severity assessment tools for ...... matic review and meta-analysis
@nl
prefLabel
Severity assessment tools for ...... matic review and meta-analysis
@ast
Severity assessment tools for ...... matic review and meta-analysis
@en
Severity assessment tools for ...... matic review and meta-analysis
@nl
P2093
P31
P921
P3181
P356
P1433
P1476
Severity assessment tools for ...... matic review and meta-analysis
@en
P2093
Adam T Hill
Ahsan R Akram
Aran Singanayagam
Gourab Choudhury
James D Chalmers
Pallavi Mandal
Philip M Short
Victoria Wood
P304
P3181
P356
10.1136/THX.2009.133280
P407
P577
2010-10-01T00:00:00Z